Maharashtra FDA bars hospitals from forcing patients to buy medicines in-house
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriers- India raises price cap on cancer drugs to tackle shortage
- UK approves Novo weight-loss pill to edge open European market
- FeaturedUTI Nifty 50 Index Direct-G0.15-9.05-4.249.26
- -3.032.227.6421.75
- 5.90-3.000.9615.23
- Regulators tighten GMP oversight of pharma plants
- India needs to remain attractive for innovation-led investment: Judith Love, Novartis
- Cancer drug prices raised 50% as NPPA acts on shortage concerns
- US drug regulator issues import alert for drugs made at a Dabur India plant
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer
- Government may lift price cap on cancer drugs making them costlier by up to 50%
- India's healthcare transformed in 12 years under PM Modi: Report
- Hetero partners with Richter to develop, market Semaglutide injection globally
- Pharma in her DNA, Wockhardt scion ready for deep dive in the US
- Duty relief may be extended for petrochemical inputs for pharma
- Insider trading: Supreme Court upholds SAT clearance to Biocon MD
Top Mutual Funds
3 M(%)
6 M(%)
1 YR(%)
3 YRS(%)
MORE NEWS
Biotech
GVK-backed Oval Fertility launched in Hyderabad, eyes share in India's growing IVF market- Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow Tucker
- Biocon shifts focus to margins, capacity utilisation after expansion phase
- Kiran Mazumdar-Shaw picks niece Claire as successor at Biocon
- Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: Report
Healthcare
India's healthcare transformed in 12 years under PM Modi: Report- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits
- Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak Securities
- PE wars to billion-dollar IPO dreams, hospital sector is fighting fit
- Warburg, KKR, TPG among PE giants vying for 25% stake in Cloudnine
Pharmaceuticals
- Maharashtra FDA bars hospitals from forcing patients to buy medicines in-house
- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriers
- India raises price cap on cancer drugs to tackle shortage
- UK approves Novo weight-loss pill to edge open European market
- Regulators tighten GMP oversight of pharma plants